These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38597597)

  • 1. The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
    Zhang X; Yang J; Feng Q; Gu L; Qin G; Cheng C; Hou S; Shi Z
    Environ Toxicol; 2024 Apr; ():. PubMed ID: 38597597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic biomarkers for cervical cancer based on programmed cell death-related genes and assessment of their immune profile and response to drug therapy.
    Feng S; Wang Z; Zhang H; Hou B; Xu Y; Hao S; Lu Y
    J Gene Med; 2024 Jan; 26(1):e3643. PubMed ID: 38044747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
    Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
    Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Li J; Xi J
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38275602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
    Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
    Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
    Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration.
    Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559
    [No Abstract]   [Full Text] [Related]  

  • 10. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
    Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
    Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang W; Cao W; Tong Z; Jin Q; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Zhou S
    Front Oncol; 2022; 12():1011000. PubMed ID: 36185274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
    Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
    Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma.
    Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ
    Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
    Lu X; Li R; Ying Y; Zhang W; Wang W
    J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZIC5 promotes aggressiveness and cancer stemness in cervical squamous cell carcinoma.
    Jia Q; Song J; Xu T; Liu J; Chai J; Yang Y; Li L; Li M; Yang X
    Pathol Res Pract; 2023 Jan; 241():154268. PubMed ID: 36495760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
    Chen D; Guo W; Yu H; Yang J
    Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Lin Q; Jiang Y; Zhou F; Zhang Y
    Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the immune landscape: a comprehensive analysis of immune-associated biomarkers in cervical carcinoma and their implications for immunotherapy strategies.
    Wang L; Liu H; Feng Y; Liu X; Wang Y; Liu Y; Li H; Zhang Y
    Front Genet; 2024; 15():1340569. PubMed ID: 38933923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
    Wu C; Ma C; Yuan J; Zhou P
    Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.